Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Sep;131(4):617-618.
doi: 10.1038/s41416-024-02808-2. Epub 2024 Jul 31.

Optimizing adjuvant treatment strategies for non-pancreatic periampullary cancers

Nouredin Messaoudi  1 , Aude Vanlander  1 , Andrew A Gumbs  2   3
Affiliations
Editorial

Optimizing adjuvant treatment strategies for non-pancreatic periampullary cancers

Nouredin Messaoudi et al. Br J Cancer. 2024 Sep.

Abstract

Non-pancreatic periampullary tumors have long been neglected, leading to blurred adjuvant treatment strategies. Recent research, like the ISGACA group's study, is uncovering nuances in chemotherapy efficacy for these diverse cancers. Tailored approaches show promise, with artificial intelligence (AI) aiding in personalized treatment plans.

PubMed Disclaimer

Conflict of interest statement

Professor Gumbs is the Editor-in-Chief of the journal Artificial Intelligence Surgery, the CEO of Talos Surgical. Professors Gumbs and Messaoudi are co-author on the AiRGOS paper cited in the references.

References

    1. Erdmann JI, Eskens FA, Vollmer CM, Kok NF, Groot Koerkamp B, Biermann K, et al. Histological and molecular subclassification of pancreatic and nonpancreatic periampullary cancers: implications for (Neo) adjuvant systemic treatment. Ann Surg Oncol. 2015;22:2401–7. 10.1245/s10434-014-4267-4 10.1245/s10434-014-4267-4 - DOI - PubMed
    1. Conroy T, Castan F, Lopez A, Turpin A, Ben Abdelghani M, Wei AC, et al. Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer. JAMA Oncol. 2022;8:1571. 10.1001/jamaoncol.2022.3829 10.1001/jamaoncol.2022.3829 - DOI - PMC - PubMed
    1. Rizzo A, Brandi G. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care. Expert Rev Gastroenterol Hepatol. 2021;15:483–5. 10.1080/17474124.2021.1864325 10.1080/17474124.2021.1864325 - DOI - PubMed
    1. Gumbs AA, Croner R, Abu-Hilal M, Bannone E, Ishizawa T, Spolverato G, et al. Surgomics and the artificial intelligence, radiomics, genomics, oncopathomics and surgomics (AiRGOS) project. Artif Intell Surg. 2023;3:180–5. 10.20517/ais.2023.24 10.20517/ais.2023.24 - DOI

Publication types

MeSH terms

LinkOut - more resources